[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Biopharma_Watch BiopharmaWatch BiopharmaWatch posts on X about $kura, $adct, $4151t, $2503t the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours. ### Engagements: XXX [#](/creator/twitter::1734221906151165952/interactions)  - X Week XXXXX -XX% - X Month XXXXXX -XX% - X Months XXXXXXX +55% - X Year XXXXXXX +328% ### Mentions: XX [#](/creator/twitter::1734221906151165952/posts_active)  - X Week XX -XX% - X Month XXX -XX% - X Months XXXXX +333% - X Year XXXXX +2,329% ### Followers: XXXXX [#](/creator/twitter::1734221906151165952/followers)  - X Week XXXXX +1.30% - X Month XXXXX +4.90% - X Months XXXXX +61% - X Year XXXXX +142% ### CreatorRank: XXXXXXXXX [#](/creator/twitter::1734221906151165952/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) XXXX% [stocks](/list/stocks) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% **Social topic influence** [$kura](/topic/$kura) #7, [$adct](/topic/$adct) #14, [$4151t](/topic/$4151t) #1, [$2503t](/topic/$2503t) #61, [$glmd](/topic/$glmd) #10, [$abos](/topic/$abos) #2, [virtual](/topic/virtual) #2292, [$tern](/topic/$tern) #286, [$tara](/topic/$tara) 2.25%, [$asbp](/topic/$asbp) XXXX% **Top accounts mentioned or mentioned by** [@maximusholla](/creator/undefined) [@monacobiotech](/creator/undefined) [@boudin420](/creator/undefined) [@martinshkreli](/creator/undefined) [@biostocks](/creator/undefined) [@yaireinhorn](/creator/undefined) [@amaymd](/creator/undefined) [@biotech2k1](/creator/undefined) **Top assets mentioned** [ADC Therapeutics SA (ADCT)](/topic/$adct) [Terns Pharmaceuticals, Inc. Common Stock (TERN)](/topic/$tern) [Taraxa (TARA)](/topic/$tara) [apM Coin (APM)](/topic/$apm) [Biogen Inc (BIIB)](/topic/$biib) [Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)](/topic/$rxrx) [Adaptive Biotechnologies Corporation Common Stock (ADPT)](/topic/$adpt) [TG Therapeutics, Inc. (TGTX)](/topic/$tgtx) ### Top Social Posts Top posts by engagements in the last XX hours "$TERN Catalyst Date - 2025-12-08 Drug - TERN-701 (novel investigational allosteric BCR::ABL1 inhibitor) Treatment - chronic myeloid leukemia (CML)" [X Link](https://x.com/Biopharma_Watch/status/1998056278250467380) 2025-12-08T15:45Z 1228 followers, XXX engagements "Top Market Movers: Negative News Full Access: $APM 1.69$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives" [X Link](https://x.com/Biopharma_Watch/status/1976675349451903424) 2025-10-10T15:45Z 1226 followers, XXX engagements "Top Market Movers: Positive News Full Access: $ADCT 4.39$ XXXX% 2025-12-01T21:05:00.000Z ADC Therapeutics Makes Grants to New Employees Under Inducement Plan" [X Link](https://x.com/Biopharma_Watch/status/1995881901463355800) 2025-12-02T15:45Z 1226 followers, XXX engagements "Latest catalysts: $TLX Catalyst Date - 2025-12-02 Drug - TLX250-CDx (Zircaix189Zr-DFO-girentuximab) Treatment - indeterminate renal masses (IRMs)" [X Link](https://x.com/Biopharma_Watch/status/1995881906215465048) 2025-12-02T15:45Z 1226 followers, XXX engagements "Latest catalysts: $TARA Catalyst Date - 2025-12-04 Drug - TARA-002 Treatment - Non-muscle invasive bladder cancer (NMIBC)" [X Link](https://x.com/Biopharma_Watch/status/1996244294328529312) 2025-12-03T15:45Z 1226 followers, XXX engagements "Top Market Movers: Negative News Full Access: $ADCT 3.13$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup" [X Link](https://x.com/Biopharma_Watch/status/1996606680730361862) 2025-12-04T15:45Z 1226 followers, XXX engagements "Latest catalysts: $TARA Catalyst Date - 2025-12-04 Drug - TARA-002 Treatment - Non-muscle invasive bladder cancer (NMIBC)" [X Link](https://x.com/Biopharma_Watch/status/1996606681615372702) 2025-12-04T15:45Z 1226 followers, XXX engagements "$BIIB Catalyst Date - 2025-12-05 Drug - Zorevunersen (investigational antisense oligonucleotide) Treatment - Dravet syndrome" [X Link](https://x.com/Biopharma_Watch/status/1996969071439761573) 2025-12-05T15:45Z 1226 followers, XX engagements "$ASBP 0.09$ -XXXXX% 2025-12-03T00:00:00.000Z Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)" [X Link](https://x.com/Biopharma_Watch/status/1996969085528350994) 2025-12-05T15:45Z 1223 followers, XXX engagements "$KURA 11.92$ XXXX% 2025-12-02T13:02:00.000Z First U.S. Commercial Sale of KOMZIFTI Triggers $XXX Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin" [X Link](https://x.com/Biopharma_Watch/status/1996244305745526790) 2025-12-03T15:45Z 1228 followers, XXX engagements "$RLMD Catalyst Date - 2025-12-04 Drug - NDV-01 (sustained release intravesical formulation of gemcitabine/docetaxel) Treatment - non-muscle invasive bladder cancer (NMIBC)" [X Link](https://x.com/Biopharma_Watch/status/1996606694525448412) 2025-12-04T15:45Z 1226 followers, XX engagements "Top Market Movers: Positive News Full Access: $INTS 0.39$ XXXX% 2025-12-04T12:47:00.000Z Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium" [X Link](https://x.com/Biopharma_Watch/status/1996969065232155001) 2025-12-05T15:45Z 1227 followers, XXX engagements "Top Market Movers: Negative News Full Access: $ADCT 3.13$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup" [X Link](https://x.com/Biopharma_Watch/status/1996969069292278043) 2025-12-05T15:45Z 1226 followers, XXX engagements "Under the hood each sleeve holds 1525 names. Q2 XX forward returns by ticker 👇 A few winners drive a big part of the upside Losers hurt but position sizing stops them from killing the portfolio Its a stock-picker alpha inside a rules-based framework" [X Link](https://x.com/Biopharma_Watch/status/1997810732344524900) 2025-12-07T23:29Z 1226 followers, XX engagements "Not just YOLO oncology. Q2 XX therapeutic mix: Conservative HF: cardio + neuro + immunology + oncology Clinical Growth / High-Vol SMID: oncology & CNS heavy with rare disease spice Midcap Core: more endocrine ophthalmic infectious disease You can see where your risk really is" [X Link](https://x.com/Biopharma_Watch/status/1997810741479342170) 2025-12-07T23:29Z 1226 followers, XXX engagements "Top Market Movers: Positive News Full Access: $GLMD 1.02$ XXXX% 2025-12-08T13:30:00.000Z Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting" [X Link](https://x.com/Biopharma_Watch/status/1998056228124274949) 2025-12-08T15:45Z 1227 followers, XXX engagements "Top Market Movers: Negative News Full Access: $AEMD 3.65$ -XXXXX% 2025-12-08T00:00:00.000Z Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement Priced At-The-Market for Aggregate Gross Proceeds of" [X Link](https://x.com/Biopharma_Watch/status/1998056233249775832) 2025-12-08T15:45Z 1228 followers, XXX engagements "$MDCX 1.72$ -XXXXX% 2025-12-08T00:00:00.000Z Medicus Pharma Ltd. Enters Into $XXX Million Warrant Inducement" [X Link](https://x.com/Biopharma_Watch/status/1998056235434918140) 2025-12-08T15:45Z 1226 followers, XX engagements "$ABOS Catalyst Date - 2025-12-02 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease" [X Link](https://x.com/Biopharma_Watch/status/1995881908321018115) 2025-12-02T15:45Z 1228 followers, XX engagements "Top Market Movers: Negative News Full Access: $ADCT 3.23$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup" [X Link](https://x.com/Biopharma_Watch/status/1996244293036740617) 2025-12-03T15:45Z 1228 followers, XXX engagements "$ABOS Catalyst Date - 2025-12-04 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease" [X Link](https://x.com/Biopharma_Watch/status/1996244295926612291) 2025-12-03T15:45Z 1228 followers, XX engagements "$JSPR 1.46$ -XXXX% 2025-12-02T00:00:00.000Z Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation" [X Link](https://x.com/Biopharma_Watch/status/1996244309449011522) 2025-12-03T15:45Z 1228 followers, XX engagements "$KURA 11.96$ XXXX% 2025-12-02T13:02:00.000Z First U.S. Commercial Sale of KOMZIFTI Triggers $XXX Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin" [X Link](https://x.com/Biopharma_Watch/status/1996606694898749905) 2025-12-04T15:45Z 1228 followers, XXX engagements "$ABOS Catalyst Date - 2025-12-04 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease" [X Link](https://x.com/Biopharma_Watch/status/1996606704952418482) 2025-12-04T15:45Z 1228 followers, XX engagements "Latest catalysts: $MNOV Catalyst Date - 2025-12-05 Drug - MN-166 (ibudilast) Treatment - Amyotrophic Lateral Sclerosis (ALS)" [X Link](https://x.com/Biopharma_Watch/status/1996969069363581432) 2025-12-05T15:45Z 1227 followers, XXX engagements "$GLMD 1.02$ XXXX% 2025-12-04T13:30:00.000Z Galmed Announces Grant of New Use Patents for the combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH" [X Link](https://x.com/Biopharma_Watch/status/1996969091169767604) 2025-12-05T15:45Z 1228 followers, XXX engagements "$PRLD Catalyst Date - 2025-12-06 Drug - JAK2V617F mutant selective inhibitors Treatment - myeloproliferative neoplasms (MPNs)" [X Link](https://x.com/Biopharma_Watch/status/1996969113080725976) 2025-12-05T15:45Z 1228 followers, XXX engagements "Biotech isnt dead. It just needed better tools. BiopharmaWatch cloned what specialist biotech hedge funds hold split it into X risk levels and ran it from Q2 XX Q2 XX. In that period $1M would have grown to as much as $2.33M. Heres how each portfolio behaves 👇 Would love to have your input/feedback on this @Maximus_Holla @monaco_biotech @boudin420 @MartinShkreli @BioStocks @yaireinhorn @A_May_MD @Biotech2k1" [X Link](https://x.com/Biopharma_Watch/status/1997810306051936724) 2025-12-07T23:27Z 1228 followers, XXX engagements "$RXRX 4.54$ XXXX% 2025-12-08T12:30:00.000Z Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks" [X Link](https://x.com/Biopharma_Watch/status/1998056241453773161) 2025-12-08T15:45Z 1228 followers, XXX engagements "$ADPT 17.34$ -XXXX% 2025-12-08T00:00:00.000Z Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ Data Driving Treatment Interventions at 2025 ASH Annual Meeting" [X Link](https://x.com/Biopharma_Watch/status/1998056259556372881) 2025-12-08T15:45Z 1228 followers, XX engagements "Top Market Movers: Positive News Full Access: $TERN 18.05$ XXXXX% November X 2025 Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annua" [X Link](https://x.com/Biopharma_Watch/status/1985735048621101516) 2025-11-04T15:45Z 1228 followers, XXX engagements "Top Market Movers: Negative News Full Access: $QNTM 9.94$ -XXXXX% 2025-11-28T14:30:00.000Z REPEAT: Award-winning Investigative News Program W5 Airs Part X of 3-part Television Series on Alleged Stock Market Manipulation of Q" [X Link](https://x.com/Biopharma_Watch/status/1994432354232967177) 2025-11-28T15:45Z 1228 followers, XXX engagements "$TGTX 33.15$ -XXXX% 2025-11-28T12:30:00.000Z TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference" [X Link](https://x.com/Biopharma_Watch/status/1994432395664371783) 2025-11-28T15:45Z 1228 followers, XXX engagements "$KURA 11.92$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid" [X Link](https://x.com/Biopharma_Watch/status/1996244288871784679) 2025-12-03T15:45Z 1228 followers, XXX engagements "$KURA 11.96$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid" [X Link](https://x.com/Biopharma_Watch/status/1996606677991432277) 2025-12-04T15:45Z 1228 followers, XXX engagements "$ASBP 0.09$ -XXXXX% 2025-12-03T00:00:00.000Z Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)" [X Link](https://x.com/Biopharma_Watch/status/1996606694693191737) 2025-12-04T15:45Z 1228 followers, 1041 engagements "$KURA 11.96$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid" [X Link](https://x.com/Biopharma_Watch/status/1996969079727706511) 2025-12-05T15:45Z 1228 followers, XXX engagements "Latest catalysts: $CGEM Catalyst Date - 2025-12-08 Drug - CLN-049 (FLT3xCD3 bispecific T cell engager) Treatment - relapsed/refractory acute myeloid leukemia (r/r AML) myelodysplastic syndrome (MDS)" [X Link](https://x.com/Biopharma_Watch/status/1998056233463677086) 2025-12-08T15:45Z 1228 followers, XXX engagements "Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $IMRN - 972.5K - 21.1M - XXXXX $QCLS - 1.9M - 38.0M - XXXXX $CLNN - 204.9K - 2.8M - 13.85" [X Link](https://x.com/Biopharma_Watch/status/1998056234906460675) 2025-12-08T15:45Z 1228 followers, XXX engagements "Top Market Movers: Negative News Full Access: $HURA 1.27$ -XXXXX% 2025-12-08T12:50:00.000Z TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to I" [X Link](https://x.com/Biopharma_Watch/status/1998418621840994341) 2025-12-09T15:45Z 1228 followers, XXX engagements "$KURA 11.03$ -XXXX% 2025-12-08T15:30:00.000Z Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML" [X Link](https://x.com/Biopharma_Watch/status/1998418636642599159) 2025-12-09T15:45Z 1228 followers, XXX engagements "$GLMD 1.17$ -XXXX% 2025-12-08T13:30:00.000Z Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting" [X Link](https://x.com/Biopharma_Watch/status/1998418654174884027) 2025-12-09T15:45Z 1228 followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Biopharma_Watch BiopharmaWatch
BiopharmaWatch posts on X about $kura, $adct, $4151t, $2503t the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX +55%
- X Year XXXXXXX +328%
Mentions: XX #
- X Week XX -XX%
- X Month XXX -XX%
- X Months XXXXX +333%
- X Year XXXXX +2,329%
Followers: XXXXX #
- X Week XXXXX +1.30%
- X Month XXXXX +4.90%
- X Months XXXXX +61%
- X Year XXXXX +142%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence finance XXXX% stocks XXXX% cryptocurrencies XXXX%
Social topic influence $kura #7, $adct #14, $4151t #1, $2503t #61, $glmd #10, $abos #2, virtual #2292, $tern #286, $tara 2.25%, $asbp XXXX%
Top accounts mentioned or mentioned by @maximusholla @monacobiotech @boudin420 @martinshkreli @biostocks @yaireinhorn @amaymd @biotech2k1
Top assets mentioned ADC Therapeutics SA (ADCT) Terns Pharmaceuticals, Inc. Common Stock (TERN) Taraxa (TARA) apM Coin (APM) Biogen Inc (BIIB) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Adaptive Biotechnologies Corporation Common Stock (ADPT) TG Therapeutics, Inc. (TGTX)
Top Social Posts
Top posts by engagements in the last XX hours
"$TERN Catalyst Date - 2025-12-08 Drug - TERN-701 (novel investigational allosteric BCR::ABL1 inhibitor) Treatment - chronic myeloid leukemia (CML)"
X Link 2025-12-08T15:45Z 1228 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $APM 1.69$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives"
X Link 2025-10-10T15:45Z 1226 followers, XXX engagements
"Top Market Movers: Positive News Full Access: $ADCT 4.39$ XXXX% 2025-12-01T21:05:00.000Z ADC Therapeutics Makes Grants to New Employees Under Inducement Plan"
X Link 2025-12-02T15:45Z 1226 followers, XXX engagements
"Latest catalysts: $TLX Catalyst Date - 2025-12-02 Drug - TLX250-CDx (Zircaix189Zr-DFO-girentuximab) Treatment - indeterminate renal masses (IRMs)"
X Link 2025-12-02T15:45Z 1226 followers, XXX engagements
"Latest catalysts: $TARA Catalyst Date - 2025-12-04 Drug - TARA-002 Treatment - Non-muscle invasive bladder cancer (NMIBC)"
X Link 2025-12-03T15:45Z 1226 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $ADCT 3.13$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup"
X Link 2025-12-04T15:45Z 1226 followers, XXX engagements
"Latest catalysts: $TARA Catalyst Date - 2025-12-04 Drug - TARA-002 Treatment - Non-muscle invasive bladder cancer (NMIBC)"
X Link 2025-12-04T15:45Z 1226 followers, XXX engagements
"$BIIB Catalyst Date - 2025-12-05 Drug - Zorevunersen (investigational antisense oligonucleotide) Treatment - Dravet syndrome"
X Link 2025-12-05T15:45Z 1226 followers, XX engagements
"$ASBP 0.09$ -XXXXX% 2025-12-03T00:00:00.000Z Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)"
X Link 2025-12-05T15:45Z 1223 followers, XXX engagements
"$KURA 11.92$ XXXX% 2025-12-02T13:02:00.000Z First U.S. Commercial Sale of KOMZIFTI Triggers $XXX Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin"
X Link 2025-12-03T15:45Z 1228 followers, XXX engagements
"$RLMD Catalyst Date - 2025-12-04 Drug - NDV-01 (sustained release intravesical formulation of gemcitabine/docetaxel) Treatment - non-muscle invasive bladder cancer (NMIBC)"
X Link 2025-12-04T15:45Z 1226 followers, XX engagements
"Top Market Movers: Positive News Full Access: $INTS 0.39$ XXXX% 2025-12-04T12:47:00.000Z Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium"
X Link 2025-12-05T15:45Z 1227 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $ADCT 3.13$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup"
X Link 2025-12-05T15:45Z 1226 followers, XXX engagements
"Under the hood each sleeve holds 1525 names. Q2 XX forward returns by ticker 👇 A few winners drive a big part of the upside Losers hurt but position sizing stops them from killing the portfolio Its a stock-picker alpha inside a rules-based framework"
X Link 2025-12-07T23:29Z 1226 followers, XX engagements
"Not just YOLO oncology. Q2 XX therapeutic mix: Conservative HF: cardio + neuro + immunology + oncology Clinical Growth / High-Vol SMID: oncology & CNS heavy with rare disease spice Midcap Core: more endocrine ophthalmic infectious disease You can see where your risk really is"
X Link 2025-12-07T23:29Z 1226 followers, XXX engagements
"Top Market Movers: Positive News Full Access: $GLMD 1.02$ XXXX% 2025-12-08T13:30:00.000Z Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting"
X Link 2025-12-08T15:45Z 1227 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $AEMD 3.65$ -XXXXX% 2025-12-08T00:00:00.000Z Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement Priced At-The-Market for Aggregate Gross Proceeds of"
X Link 2025-12-08T15:45Z 1228 followers, XXX engagements
"$MDCX 1.72$ -XXXXX% 2025-12-08T00:00:00.000Z Medicus Pharma Ltd. Enters Into $XXX Million Warrant Inducement"
X Link 2025-12-08T15:45Z 1226 followers, XX engagements
"$ABOS Catalyst Date - 2025-12-02 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease"
X Link 2025-12-02T15:45Z 1228 followers, XX engagements
"Top Market Movers: Negative News Full Access: $ADCT 3.23$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup"
X Link 2025-12-03T15:45Z 1228 followers, XXX engagements
"$ABOS Catalyst Date - 2025-12-04 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease"
X Link 2025-12-03T15:45Z 1228 followers, XX engagements
"$JSPR 1.46$ -XXXX% 2025-12-02T00:00:00.000Z Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation"
X Link 2025-12-03T15:45Z 1228 followers, XX engagements
"$KURA 11.96$ XXXX% 2025-12-02T13:02:00.000Z First U.S. Commercial Sale of KOMZIFTI Triggers $XXX Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin"
X Link 2025-12-04T15:45Z 1228 followers, XXX engagements
"$ABOS Catalyst Date - 2025-12-04 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease"
X Link 2025-12-04T15:45Z 1228 followers, XX engagements
"Latest catalysts: $MNOV Catalyst Date - 2025-12-05 Drug - MN-166 (ibudilast) Treatment - Amyotrophic Lateral Sclerosis (ALS)"
X Link 2025-12-05T15:45Z 1227 followers, XXX engagements
"$GLMD 1.02$ XXXX% 2025-12-04T13:30:00.000Z Galmed Announces Grant of New Use Patents for the combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH"
X Link 2025-12-05T15:45Z 1228 followers, XXX engagements
"$PRLD Catalyst Date - 2025-12-06 Drug - JAK2V617F mutant selective inhibitors Treatment - myeloproliferative neoplasms (MPNs)"
X Link 2025-12-05T15:45Z 1228 followers, XXX engagements
"Biotech isnt dead. It just needed better tools. BiopharmaWatch cloned what specialist biotech hedge funds hold split it into X risk levels and ran it from Q2 XX Q2 XX. In that period $1M would have grown to as much as $2.33M. Heres how each portfolio behaves 👇 Would love to have your input/feedback on this @Maximus_Holla @monaco_biotech @boudin420 @MartinShkreli @BioStocks @yaireinhorn @A_May_MD @Biotech2k1"
X Link 2025-12-07T23:27Z 1228 followers, XXX engagements
"$RXRX 4.54$ XXXX% 2025-12-08T12:30:00.000Z Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks"
X Link 2025-12-08T15:45Z 1228 followers, XXX engagements
"$ADPT 17.34$ -XXXX% 2025-12-08T00:00:00.000Z Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ Data Driving Treatment Interventions at 2025 ASH Annual Meeting"
X Link 2025-12-08T15:45Z 1228 followers, XX engagements
"Top Market Movers: Positive News Full Access: $TERN 18.05$ XXXXX% November X 2025 Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annua"
X Link 2025-11-04T15:45Z 1228 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $QNTM 9.94$ -XXXXX% 2025-11-28T14:30:00.000Z REPEAT: Award-winning Investigative News Program W5 Airs Part X of 3-part Television Series on Alleged Stock Market Manipulation of Q"
X Link 2025-11-28T15:45Z 1228 followers, XXX engagements
"$TGTX 33.15$ -XXXX% 2025-11-28T12:30:00.000Z TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference"
X Link 2025-11-28T15:45Z 1228 followers, XXX engagements
"$KURA 11.92$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid"
X Link 2025-12-03T15:45Z 1228 followers, XXX engagements
"$KURA 11.96$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid"
X Link 2025-12-04T15:45Z 1228 followers, XXX engagements
"$ASBP 0.09$ -XXXXX% 2025-12-03T00:00:00.000Z Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)"
X Link 2025-12-04T15:45Z 1228 followers, 1041 engagements
"$KURA 11.96$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid"
X Link 2025-12-05T15:45Z 1228 followers, XXX engagements
"Latest catalysts: $CGEM Catalyst Date - 2025-12-08 Drug - CLN-049 (FLT3xCD3 bispecific T cell engager) Treatment - relapsed/refractory acute myeloid leukemia (r/r AML) myelodysplastic syndrome (MDS)"
X Link 2025-12-08T15:45Z 1228 followers, XXX engagements
"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $IMRN - 972.5K - 21.1M - XXXXX $QCLS - 1.9M - 38.0M - XXXXX $CLNN - 204.9K - 2.8M - 13.85"
X Link 2025-12-08T15:45Z 1228 followers, XXX engagements
"Top Market Movers: Negative News Full Access: $HURA 1.27$ -XXXXX% 2025-12-08T12:50:00.000Z TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to I"
X Link 2025-12-09T15:45Z 1228 followers, XXX engagements
"$KURA 11.03$ -XXXX% 2025-12-08T15:30:00.000Z Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML"
X Link 2025-12-09T15:45Z 1228 followers, XXX engagements
"$GLMD 1.17$ -XXXX% 2025-12-08T13:30:00.000Z Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting"
X Link 2025-12-09T15:45Z 1228 followers, XX engagements